from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0051/-

LFCtreatmentdescriptionclass of inhibitor

-0.303

Amikacinug/mL Amikacintranslation

-0.843

Cap5-10ug/mL Capreomycintranslation

-0.705

Rox10-50 ug/mL Roxithromycintranslation

-0.084

SM2-5 ug/mL Streptomycintranslation

-4.410

Tet5-10 ug/mL Tetracyclinetranslation

0.073

Rif0.2-5ug/mL Rifampicintranscription

-0.247

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.158

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.583

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.421

CPZ10-50 ug/mL Chlorpromazinerespiration

1.515

Clofazimine10-13 ug/mL Clofaziminerespiration

0.632

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.232

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.589

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.916

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.872

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.510

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.480

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.881

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.589

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.561

KCN5-20 ug/mL Potassium cyaniderespiration

0.030

NaN30.2-2 mM Sodium aziderespiration

-0.098

Nigericin50 uM Nigericinrespiration

0.542

TRC10-150 ug/mL Triclosanrespiration

-0.667

TRZ10-25 ug/mL Thioridazinerespiration

-2.619

Valinomycin0.5-10 uM Valinomycinrespiration

0.582

ZnSO42 mM ZnSO4respiration

-1.129

menadione6-10 ug/mL Menadionerespiration

-0.061

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.163

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.122

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.324

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.095

NRP_1Non-replicating persistence stage 1dosRassociated

-0.223

Amp0.2mg/mL AmpicillincellWall

0.025

Cephalexin20-100 ug/mL CephalexincellWall

-0.335

Cerulenin0.32-5 ug/mL CerulenincellWall

0.021

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.575

EMB10-20 ug/mL EthambutolcellWall

0.232

Eta12-40 ug/mL EthionamidecellWall

-0.224

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.327

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.907

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.323

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.805

BZA0.12 mg/mL BenzamidearomaticAmides

0.539

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.467

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.339

H2O24 mM hydrogen peroxideDNAdamaging

-0.105

Levo10 ug/mL LevofloxacinDNAdamaging

-0.468

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.441

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.060

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.220

UVUV-irradiationDNAdamaging

-0.025

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.142

Antimycin12.5-50 ug/mL Antimycin A?

-0.366

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.616

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.146

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.495

PA8240.2-2 ug/mL PA-824?

-0.013

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.259

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.002

Verapamil50 uM Verapamil?

-0.251

mercaptoethanol2 mM 2-Mercaptoethanol?

0.034

methoxatin10-20 ug/mL Methoxatin?